| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-3083.2003.01176.X |
| P698 | PubMed publication ID | 12542793 |
| P2093 | author name string | O Ringdén | |
| K Le Blanc | |||
| S E Haynesworth | |||
| B Sundberg | |||
| L Tammik | |||
| P433 | issue | 1 | |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 11-20 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Scandinavian Journal of Immunology | Q15762682 |
| P1476 | title | Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex | |
| P478 | volume | 57 |
| Q45863718 | * CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments |
| Q38730229 | A Comparison of Culture Characteristics between Human Amniotic Mesenchymal Stem Cells and Dental Stem Cells |
| Q52595136 | A Novel Mechanism of Mesenchymal Stromal Cell-Mediated Protection against Sepsis: Restricting Inflammasome Activation in Macrophages by Increasing Mitophagy and Decreasing Mitochondrial ROS. |
| Q90034592 | A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease |
| Q36944312 | A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia |
| Q33570359 | A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype |
| Q34979619 | A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression |
| Q64079806 | Activated Mesenchymal Stromal Cells Process and Present Antigens Regulating Adaptive Immunity |
| Q38936385 | Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression. |
| Q34571474 | Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures |
| Q37825285 | Adipose tissue as a stem cell source for musculoskeletal regeneration |
| Q28534075 | Adipose tissue-derived mesenchymal stem cells increase skin allograft survival and inhibit Th-17 immune response |
| Q53752727 | Adipose tissue-derived stem cells show both immunogenic and immunosuppressive properties after chondrogenic differentiation |
| Q28074625 | Adipose-Derived Stem Cells as a Tool in Cell-Based Therapies |
| Q55229989 | Adipose-derived mesenchymal stem cell-derived exosomes alleviate overwhelming systemic inflammatory reaction and organ damage and improve outcome in rat sepsis syndrome. |
| Q92764797 | Adipose-derived mesenchymal stem cells ameliorate acute liver injury in rat model of CLP induced-sepsis via sTNFR1 |
| Q79368670 | Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft |
| Q34135233 | Advances in mesenchymal stem cell-mediated gene therapy for cancer. |
| Q37529754 | Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo |
| Q84693148 | Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats |
| Q84195701 | Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease |
| Q45172430 | Allogenic transplantation of human mesenchymal stem cells for tissue engineering purposes: an in vitro study |
| Q34423210 | Allograftic bone marrow-derived mesenchymal stem cells transplanted into heart infarcted model of rabbit to renovate infarcted heart |
| Q64276493 | Ally to adversary: mesenchymal stem cells and their transformation in leukaemia |
| Q33745996 | Apoptotic adipose-derived mesenchymal stem cell therapy protects against lung and kidney injury in sepsis syndrome caused by cecal ligation puncture in rats. |
| Q32178661 | Are Sertoli cells a kind of mesenchymal stem cells? |
| Q47098959 | Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs). |
| Q45003616 | Autoimmune disease: is it a disorder of the microenvironment? |
| Q36051445 | Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells |
| Q51770946 | BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO. |
| Q92134661 | Bidirectional and Opposite Effects of Naïve Mesenchymal Stem Cells on Tumor Growth and Progression |
| Q36509174 | Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets. |
| Q40092032 | Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency. |
| Q35653129 | Bone marrow and the control of immunity |
| Q34183356 | Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat model |
| Q34553368 | Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes |
| Q82221039 | Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion |
| Q52679939 | Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T-cell immune responses via PD-1/PD-L1 pathway. |
| Q34361237 | Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice |
| Q34171231 | CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells |
| Q40107992 | CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties |
| Q42205058 | CD90(+) human dermal stromal cells are potent inducers of FoxP3(+) regulatory T cells. |
| Q35881348 | CTLA4 enhances the osteogenic differentiation of allogeneic human mesenchymal stem cells in a model of immune activation. |
| Q35599947 | Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation |
| Q35177936 | Cardiac migration of endogenous mesenchymal stromal cells in patients with inflammatory cardiomyopathy |
| Q24534652 | Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction |
| Q45834735 | Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. |
| Q35868954 | Cell therapy for autoimmune diseases |
| Q27026350 | Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells |
| Q36669952 | Cellular cardiomyoplasty by catheter-based infusion of stem cells in clinical settings |
| Q37236894 | Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease |
| Q37220543 | Cellular therapy of systemic sclerosis |
| Q34063611 | Characterization of the enhanced bone regenerative capacity of human periodontal ligament stem cells engineered to express the gene encoding bone morphogenetic protein 2. |
| Q40590332 | Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. |
| Q37970678 | Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease |
| Q37867953 | Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells |
| Q91872118 | Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease |
| Q36923358 | Clinical-scale expansion of mesenchymal stromal cells: a large banking experience |
| Q34064517 | Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response |
| Q37220504 | Co-transplantation of human mesenchymal stem cells promotes human CD34+ cells engraftment in a dose-dependent fashion in NOD/SCID mice |
| Q42030085 | Combined Therapy With Adipose-Derived Mesenchymal Stem Cells and Ciprofloxacin Against Acute Urogenital Organ Damage in Rat Sepsis Syndrome Induced by Intrapelvic Injection of Cecal Bacteria |
| Q42868553 | Comparative study of immune regulatory properties of stem cells derived from different tissues |
| Q98568270 | Comparison of freshly cultured versus freshly thawed (cryopreserved) mesenchymal stem cells in preclinical in vivo models of inflammation: a protocol for a preclinical systematic review and meta-analysis |
| Q26785907 | Comprehensive Review of Adipose Stem Cells and Their Implication in Distraction Osteogenesis and Bone Regeneration |
| Q33553011 | Concise Review: Fat and Furious: Harnessing the Full Potential of Adipose-Derived Stromal Vascular Fraction |
| Q33722631 | Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes |
| Q35200156 | Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies |
| Q42237319 | Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects |
| Q39296574 | Cord-blood-derived mesenchymal stromal cells downmodulate CD4+ T-cell activation by inducing IL-10-producing Th1 cells |
| Q31136667 | Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation |
| Q45869865 | Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation |
| Q82645195 | Cotransplantation of umbilical cord MSCs to enhance engraftment of hematopoietic stem cells in patients with severe aplastic anemia |
| Q46728495 | Cultured bone marrow cell local implantation accelerates healing of ulcers in mice |
| Q33642625 | Current and future approaches for control of graft-versus-host disease |
| Q37989375 | Cutaneous graft-versus-host disease--clinical considerations and management |
| Q36997847 | Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury. |
| Q46632528 | Differential function of the alpha2A-adrenoceptor and Phosphodiesterase-3B in human adipocytes of different origin |
| Q24328974 | Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: a dose-dependent effect of osterix over-expression |
| Q37472831 | Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells? |
| Q35240062 | Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? |
| Q38220496 | Do dental stem cells depict distinct characteristics? - Establishing their "phenotypic fingerprint". |
| Q37501897 | Do mesenchymal stem cells modulate the milieu of reconstructed bladder wall? |
| Q35849125 | Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting |
| Q37255164 | Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary results |
| Q58274468 | Effect of kidney-reinforcing, blood-activating and stasis-removing recipes on adhesion molecule expression of bone marrow mesenchymal stem cells from chronic aplastic anemia patients |
| Q95819687 | Effect of peripheral blood-derived mesenchymal stem cells on macrophage polarization and Th17/Treg balance in vitro |
| Q44678507 | Effective protection against acute respiratory distress syndrome/sepsis injury by combined adipose-derived mesenchymal stem cells and preactivated disaggregated platelets |
| Q26740408 | Effects of Oxidative Stress on Mesenchymal Stem Cell Biology |
| Q96134602 | Effects of cryopreservation and long-term culture on biological characteristics and proteomic profiles of human umbilical cord-derived mesenchymal stem cells |
| Q34053889 | Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells |
| Q42041237 | Efficacy of Human Umbilical Stem Cells Cultured on Polylactic/ Polyglycolic Acid Membrane in the Treatment of Multiple Gingival Recession Defects: a Randomized Controlled Clinical Study |
| Q80809795 | Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep |
| Q37781668 | Emerging therapeutic approaches for multipotent mesenchymal stromal cells |
| Q36077391 | Engineering bone: challenges and obstacles. |
| Q92801341 | Enhancement of Mesenchymal Stem Cell-Driven Bone Regeneration by Resveratrol-Mediated SOX2 Regulation |
| Q35551421 | Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo. |
| Q39150444 | Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro. |
| Q82478055 | Evaluation of Cellular and Humoral Immune Responses to Allogeneic Adipose-Derived Stem/Stromal Cells |
| Q34421548 | Evaluation of isolation methods and culture conditions for rat bone marrow mesenchymal stem cells |
| Q37607979 | Ex vivo expansion of cord blood |
| Q37788414 | Ex vivo expansion of umbilical cord blood for transplantation |
| Q34275817 | Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth |
| Q38565249 | Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro |
| Q36247051 | Fas ligand regulates the immunomodulatory properties of dental pulp stem cells |
| Q52722969 | Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy. |
| Q34503682 | Fetal microchimerism persists at high levels in c-kit stem cells in sensitized mothers |
| Q42702003 | Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential |
| Q30590485 | Fibroblast Growth Factor-2 alone as an efficient inducer for differentiation of human bone marrow mesenchymal stem cells into dopaminergic neurons |
| Q35986119 | Foxp3-modified bone marrow mesenchymal stem cells promotes liver allograft tolerance through the generation of regulatory T cells in rats |
| Q57177288 | Future Perspectives on the Role of Stem Cells and Extracellular Vesicles in Vascular Tissue Regeneration |
| Q38096939 | Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells. |
| Q36502713 | Gene delivery strategies for cartilage tissue engineering |
| Q45862169 | Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis |
| Q41871833 | Generation of an immortalized mesenchymal stem cell line producing a secreted biosensor protein for glucose monitoring |
| Q64054712 | Graft-versus-host disease in a child with neuroblastoma after autologous stem cell transplantation |
| Q79149793 | HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells |
| Q37355610 | HSCT recipients have specific tolerance to MSC but not to the MSC donor |
| Q38032498 | Harnessing the immunomodulatory and tissue repair properties of mesenchymal stem cells to restore β cell function |
| Q33605156 | Heart failure management: the present and the future |
| Q37235006 | Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors |
| Q33776557 | How stem cells speak with host immune cells in inflammatory brain diseases |
| Q47158019 | Human Articular Chondrocytes Induce Interleukin-2 Nonresponsiveness to Allogeneic Lymphocytes |
| Q34306920 | Human Bone Marrow Derived Mesenchymal Stem Cells Regulate Leukocyte-Endothelial Interactions and Activation of Transcription Factor NF-Kappa B. |
| Q30853758 | Human Bone Marrow Mesenchymal Stem/Stromal Cells Preserve Their Immunomodulatory and Chemotactic Properties When Expanded in a Human Plasma Derived Xeno-Free Medium |
| Q38439453 | Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model. |
| Q48649284 | Human Umbilical Cord Mesenchymal Stem Cells Overexpressing Nerve Growth Factor Ameliorate Diabetic Cystopathy in Rats |
| Q88107887 | Human adipose tissue derived pericytes increase life span in Utrn (tm1Ked) Dmd (mdx) /J mice |
| Q54401772 | Human adipose tissue−derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1−mediated inhibition of NF-κB signaling |
| Q34803950 | Human bone marrow-derived mesenchymal stem cells |
| Q37106884 | Human embryonic mesenchymal stem cells participate in differentiation of renal tubular cells in newborn mice |
| Q34576397 | Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies |
| Q35681446 | Human embryonic stem cell-derived mesenchymal stromal cells |
| Q43092676 | Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. |
| Q34729151 | Human mesenchymal stem cell co-culture modulates the immunological properties of human intervertebral disc tissue fragments in vitro |
| Q28071916 | Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials |
| Q40600413 | Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation |
| Q27004008 | Human mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applications |
| Q39840459 | Human multipotent mesenchymal stromal cells from distinct sources show different in vivo potential to differentiate into muscle cells when injected in dystrophic mice. |
| Q35986182 | Human umbilical cord blood-derived stromal cells are superior to human umbilical cord blood-derived mesenchymal stem cells in inducing myeloid lineage differentiation in vitro |
| Q37309075 | Human umbilical cord blood-derived stromal cells suppress xenogeneic immune cell response in vitro |
| Q54401068 | IDO1 and IDO2 gene expression analysis by quantitative polymerase chain reaction |
| Q53575224 | IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation. |
| Q39090056 | Icariin-treated human umbilical cord mesenchymal stem cells decrease chronic liver injury in mice |
| Q55519462 | Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. |
| Q55434861 | Immune Modulation by Mesenchymal Stem Cells. |
| Q36456612 | Immune modulation by mesenchymal stem cells |
| Q39478990 | Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells |
| Q86630981 | Immune tolerance of amniotic fluid stem cell-induced rat kidney graft and influences on oxidative stress |
| Q51132039 | Immunogenicity and immune modulation of osteogenic differentiated mesenchymal stem cells from Banna minipig inbred line. |
| Q33582286 | Immunogenicity of undifferentiated and differentiated allogeneic mouse mesenchymal stem cells |
| Q37285049 | Immunologic properties of differentiated and undifferentiated mesenchymal stem cells derived from umbilical cord blood |
| Q26852467 | Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells |
| Q37496081 | Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantion on hyperglycemia in diabetic rats |
| Q39723551 | Immunological characteristics of mesenchymal stem cells |
| Q41998193 | Immunological properties of embryonic and adult stem cells |
| Q81796868 | Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease |
| Q92862965 | Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs |
| Q89833740 | Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications |
| Q24644691 | Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes |
| Q57175340 | Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future |
| Q34473179 | Immunomodulative effects of mesenchymal stem cells derived from human embryonic stem cells in vivo and in vitro |
| Q84878975 | Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate |
| Q34224955 | Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. |
| Q73664290 | Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells |
| Q84439284 | Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets |
| Q36990126 | Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy |
| Q80035881 | Immunomodulatory functions of mesenchymal stem cells |
| Q38177278 | Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy. |
| Q37847217 | Immunomodulatory properties and therapeutic application of mesenchymal stem cells |
| Q35769026 | Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005 |
| Q88092087 | Immunoregulation effects of bone marrow-derived mesenchymal stem cells in xenogeneic acellular nerve grafts transplant |
| Q42000663 | Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the nasal polyp microenvironment. |
| Q36609696 | Immunoregulatory function of mesenchymal stem cells |
| Q37760962 | Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications |
| Q42152726 | Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid |
| Q79838800 | Immunosuppressive properties of cloned bone marrow mesenchymal stem cells |
| Q37926524 | Immunosuppressive properties of mesenchymal stem cells |
| Q27023323 | Immunotherapeutic potential of extracellular vesicles |
| Q36786033 | Immunotherapy by allogeneic stem cell transplantation |
| Q36380188 | Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects |
| Q36527041 | Impact of apoptotic adipose-derived mesenchymal stem cells on attenuating organ damage and reducing mortality in rat sepsis syndrome induced by cecal puncture and ligation. |
| Q37872602 | In vitro Differentiation Potential of Mesenchymal Stem Cells |
| Q34870479 | In vivo Differentiation Potential of Mesenchymal Stem Cells: Prenatal and Postnatal Model Systems. |
| Q42281235 | In-vitro characterization of canine multipotent stromal cells isolated from synovium, bone marrow, and adipose tissue: a donor-matched comparative study. |
| Q47111498 | Inferior In Vivo Osteogenesis and Superior Angiogeneis of Human Adipose Tissue: A Comparison with Bone Marrow-Derived Stromal Stem Cells Cultured in Xeno-Free Conditions. |
| Q41981124 | Influence of mesenchymal stem cells on cryopreserved tracheal allografts in rabbits |
| Q42030296 | Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype |
| Q52717834 | Interventions for lower extremity peripheral artery disease. |
| Q37281919 | Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence |
| Q53608103 | Intranasal delivery of central nervous system-retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis. |
| Q58776138 | Intravenous Infusion of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Rheumatoid Arthritis: A Phase Ia Clinical Trial |
| Q81169777 | Isolation, characterization, and differentiation of human umbilical cord perivascular cells (HUCPVCs) |
| Q92599884 | Kinetics of MSC-based enzyme therapy for immunoregulation |
| Q81000071 | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells |
| Q55115817 | MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu. |
| Q91940433 | MSC: immunoregulatory effects, roles on neutrophils and evolving clinical potentials |
| Q40952623 | Magnetic induction heating of superparamagnetic nanoparticles during rewarming augments the recovery of hUCM-MSCs cryopreserved by vitrification |
| Q39445337 | Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles |
| Q46307085 | Mammalian MSC from selected species: Features and applications |
| Q33852356 | Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier |
| Q42103653 | Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: what do we know so far? |
| Q28079649 | Mechanisms of mesenchymal stem/stromal cell function |
| Q41976611 | Mechanisms of the immunosuppressive effects of mouse adipose tissue-derived mesenchymal stromal cells on mouse alloreactively stimulated spleen cells |
| Q93020627 | Mechanisms utilized by feline adipose-derived mesenchymal stem cells to inhibit T lymphocyte proliferation |
| Q34420558 | Melatonin augments apoptotic adipose-derived mesenchymal stem cell treatment against sepsis-induced acute lung injury |
| Q48247347 | Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia. |
| Q57170602 | Mesenchymal Stem Cell Derived Exosomes in Cancer Progression, Metastasis and Drug Delivery: A Comprehensive Review |
| Q28079089 | Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence |
| Q47171663 | Mesenchymal Stem Cell-Conditioned Medium Reduces Disease Severity and Immune Responses in Inflammatory Arthritis |
| Q61878551 | Mesenchymal Stem Cells Require a Sufficient, Ongoing Immune Response to Exert Their Immunosuppressive Function |
| Q64086168 | Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines |
| Q59808674 | Mesenchymal Stem Cells Shift Mitochondrial Dynamics and Enhance Oxidative Phosphorylation in Recipient Cells |
| Q26741252 | Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation |
| Q90411558 | Mesenchymal Stem Cells from Human Exfoliated Deciduous Teeth and the Orbicularis Oris Muscle: How Do They Behave When Exposed to a Proinflammatory Stimulus? |
| Q37677012 | Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage |
| Q91675894 | Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients |
| Q37809081 | Mesenchymal Stem Cells: Mechanisms of Inflammation |
| Q26864580 | Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus |
| Q39419410 | Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles and Their Potential as Novel Immunomodulatory Therapeutic Agents |
| Q42359309 | Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression. |
| Q26800098 | Mesenchymal Stromal Cells Affect Disease Outcomes via Macrophage Polarization |
| Q34520475 | Mesenchymal Stromal Cells Fail to Prevent Acute Graft-versus-Host Disease and Graft Rejection after Dog Leukocyte Antigen-Haploidentical Bone Marrow Transplantation |
| Q92630103 | Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine |
| Q38831977 | Mesenchymal Stromal Cells from Osteoarthritic Synovium Are a Distinct Population Compared to Their Bone-Marrow Counterparts regarding Surface Marker Distribution and Immunomodulation of Allogeneic CD4+ T-Cell Cultures. |
| Q41831728 | Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy |
| Q37345076 | Mesenchymal stem cell therapy for refractory scleroderma: a report of 2 cases |
| Q35971980 | Mesenchymal stem cell therapy in the treatment of acute and chronic graft versus host disease |
| Q26999783 | Mesenchymal stem cell transplantation in multiple sclerosis |
| Q45864277 | Mesenchymal stem cell transplantation: A potential therapy for oral lichen planus |
| Q45173763 | Mesenchymal stem cell treatments in rheumatology: a glass half full? |
| Q36546424 | Mesenchymal stem cell-based therapy |
| Q55096337 | Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis. |
| Q53628192 | Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual. |
| Q26853374 | Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment |
| Q39217547 | Mesenchymal stem cells as an appropriate feeder layer for prolonged in vitro culture of human induced pluripotent stem cells |
| Q37138080 | Mesenchymal stem cells as therapeutics |
| Q34349428 | Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery |
| Q34676808 | Mesenchymal stem cells at the intersection of cell and gene therapy |
| Q35171621 | Mesenchymal stem cells derived from human exfoliated deciduous teeth (SHEDs) induce immune modulatory profile in monocyte-derived dendritic cells |
| Q38334043 | Mesenchymal stem cells derived in vitro transdifferentiated insulin-producing cells: A new approach to treat type 1 diabetes |
| Q29617267 | Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study |
| Q41486806 | Mesenchymal stem cells from human umbilical cord ameliorate testicular dysfunction in a male rat hypogonadism model |
| Q42420323 | Mesenchymal stem cells in arthritis: role of bone marrow microenvironment. |
| Q37194081 | Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities |
| Q38127615 | Mesenchymal stem cells in the treatment of pediatric diseases |
| Q79208808 | Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells |
| Q27003059 | Mesenchymal stem cells migration homing and tracking |
| Q47556084 | Mesenchymal stem cells therapy protects fetuses from resorption and induces Th2 type cytokines profile in abortion prone mouse model |
| Q83074981 | Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts |
| Q42133000 | Mesenchymal stem cells: From bench to bedside |
| Q37094023 | Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy |
| Q41972500 | Mesenchymal stem cells: from biology to clinical use |
| Q27003371 | Mesenchymal stem cells: immune evasive, not immune privileged |
| Q37536886 | Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. |
| Q34422955 | Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. |
| Q37880625 | Mesenchymal stromal cell 'licensing': a multistep process |
| Q37645095 | Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response? |
| Q38014753 | Mesenchymal stromal cells (MSCs): science and f(r)iction |
| Q36014812 | Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation |
| Q33958064 | Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses |
| Q37745268 | Mesenchymal stromal cells inhibit CD25 expression via the mTOR pathway to potentiate T-cell suppression |
| Q42187260 | Mesenchymal stromal cells inhibit proliferation of virus-specific CD8(+) T cells |
| Q35296873 | Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation |
| Q36110181 | Mesenchymal stromal cells support endothelial cell interactions in an intramuscular islet transplantation model |
| Q35848391 | Mesenchymal stromal cells: a new tool against graft-versus-host disease? |
| Q34234464 | Mesenchymal stromal cells: current understanding and clinical status |
| Q36975488 | Mesenchymal stromal cells: heroes or non-combatants? |
| Q36832887 | Microchimerism and stem cell transplantation in multiple sclerosis |
| Q39838854 | Microdystrophin Delivery in Dystrophin-Deficient (mdx) Mice by Genetically-Corrected Syngeneic MSCs Transplantation |
| Q33576396 | Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells |
| Q35440052 | Mixed serum-deprived and normal adipose-derived mesenchymal stem cells against acute lung ischemia-reperfusion injury in rats |
| Q37772403 | Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential |
| Q35176487 | Mononuclear cell secretome protects from experimental autoimmune myocarditis |
| Q37737100 | Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. |
| Q34791234 | Multipotent Mesenchymal Stromal Cells for Autoimmune Diseases |
| Q37133654 | Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-met and STAT3 |
| Q37421286 | Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. |
| Q30478228 | Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. |
| Q35843862 | Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response |
| Q33802826 | Mycoplasma contamination revisited: mesenchymal stromal cells harboring Mycoplasma hyorhinis potently inhibit lymphocyte proliferation in vitro |
| Q37591126 | Myogenic-induced mesenchymal stem cells are capable of modulating the immune response by regulatory T cells |
| Q57463649 | NANOmetric BIO-Banked MSC-Derived Exosome (NANOBIOME) as a Novel Approach to Regenerative Medicine |
| Q33999073 | Netrin-1 induces MMP-12-dependent E-cadherin degradation via the distinct activation of PKCα and FAK/Fyn in promoting mesenchymal stem cell motility |
| Q37435052 | Netrin-1-Induced Stem Cell Bioactivity Contributes to the Regeneration of Injured Tissues via the Lipid Raft-Dependent Integrin α6β4 Signaling Pathway |
| Q37396444 | New era of cell-based orthopedic therapies. |
| Q33781303 | Omental adipose tissue is a more suitable source of canine Mesenchymal stem cells |
| Q85121641 | Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation |
| Q35986211 | Oral mucosal progenitor cells are potently immunosuppressive in a dose-independent manner. |
| Q36142956 | Overexpression of Glutamate Decarboxylase in Mesenchymal Stem Cells Enhances Their Immunosuppressive Properties and Increases GABA and Nitric Oxide Levels. |
| Q33787406 | Persistent circulating human insulin in sheep transplanted in utero with human mesenchymal stem cells |
| Q79345396 | Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma |
| Q35527042 | Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells |
| Q35563481 | Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC. |
| Q38165928 | Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures |
| Q34791203 | Points to Consider in Designing Mesenchymal Stem Cell-Based Clinical Trials |
| Q82452899 | Pooled MSCs for treatment of severe hemorrhage |
| Q40140807 | Potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells |
| Q90213647 | Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury |
| Q41091183 | Preclinical evaluation of the immunomodulatory properties of cardiac adipose tissue progenitor cells using umbilical cord blood mesenchymal stem cells: a direct comparative study |
| Q34577332 | Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation |
| Q80791315 | Prevention of graft-versus-host disease by intrabone marrow injection of donor T cells: involvement of bone marrow stromal cells |
| Q36431047 | Prevention of graft-vs.-host disease |
| Q63257365 | Progenitor cells trapped in marrow filters can reduce GvHD and transplant mortality |
| Q27015716 | Progress of mesenchymal stem cell therapy for neural and retinal diseases |
| Q39352677 | Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells. |
| Q35927391 | Rat mesenchymal stromal cells inhibit T cell proliferation but not cytokine production through inducible nitric oxide synthase |
| Q62632796 | Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial |
| Q33842767 | Reactive oxygen species induce MMP12-dependent degradation of collagen 5 and fibronectin to promote the motility of human umbilical cord-derived mesenchymal stem cells |
| Q38568116 | Recent Patents Pertaining to Immune Modulation and Musculoskeletal Regeneration with Wharton's Jelly Cells |
| Q27007493 | Recent progress toward understanding the physiological function of bone marrow mesenchymal stem cells |
| Q54942512 | Recovery of Donor Hematopoiesis after Graft Failure and Second Hematopoietic Stem Cell Transplantation with Intraosseous Administration of Mesenchymal Stromal Cells. |
| Q34138063 | Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions |
| Q33385098 | Resolution of refractory chronic autoimmune thrombocytopenic purpura following mesenchymal stem cell transplantation: a case report |
| Q36915887 | Role of Human Corneal Stroma-Derived Mesenchymal-Like Stem Cells in Corneal Immunity and Wound Healing |
| Q35665321 | Role of hepatocyte growth factor in the immunomodulation potential of amniotic fluid stem cells |
| Q37995012 | Role of mesenchymal stem cell therapy in Crohn's disease |
| Q37589437 | Role of mesenchymal stem cells in cell life and their signaling |
| Q84099902 | Role of mesenchymal stem cells in immunological rejection of organ transplantation |
| Q37227244 | Role of mesenchymal stromal cells in solid organ transplantation |
| Q89105506 | Roles of Mesenchymal Stem Cells in Tissue Regeneration and Immunomodulation |
| Q59135921 | Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study |
| Q40119705 | Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis. |
| Q37020401 | Safety of Intraperitoneal Injection of Adipose Tissue-Derived Autologous Mesenchymal Stem Cells in Cats |
| Q37196123 | Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantation |
| Q38151905 | Serum-free media for the production of human mesenchymal stromal cells: a review. |
| Q35601464 | Simvastatin modulates mesenchymal stromal cell proliferation and gene expression |
| Q62785713 | Stem Cell Applications in Corneal Regeneration and Wound Repair |
| Q38146735 | Stem Cells for Neurovascular Repair in Stroke. |
| Q34369195 | Stem cell microchimerism and tolerance to non-inherited maternal antigens |
| Q37354837 | Stem cell therapy for heart failure |
| Q39850212 | Stem cell therapy for ischemic heart disease |
| Q37800307 | Stem cell transplantation: progress in Asia |
| Q26745715 | Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls |
| Q37073810 | Stem cells for liver tissue repair: current knowledge and perspectives |
| Q37781919 | Stem cells in the treatment of inflammatory arthritis |
| Q36712808 | Stem cells in the umbilical cord |
| Q42264693 | Stem cells isolated from the human stromal limbus possess immunosuppressant properties. |
| Q55401793 | Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models. |
| Q26851908 | Stromal cell-based immunotherapy in transplantation |
| Q45793070 | Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro. |
| Q38181957 | Stromal cells-are they really useful for GVHD? |
| Q42160266 | Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells |
| Q46142905 | Suppression of cellular immunity by cord blood-derived unrestricted somatic stem cells is cytokine-dependent |
| Q35683498 | Systematic implantation of dedifferentiated fat cells ameliorated monoclonal antibody 1-22-3-induced glomerulonephritis by immunosuppression with increases in TNF-stimulated gene 6. |
| Q36155376 | Systemic Administration of Allogeneic Mesenchymal Stem Cells Does Not Halt Osteoporotic Bone Loss in Ovariectomized Rats |
| Q39898293 | Telomerase immortalized human amnion- and adipose-derived mesenchymal stem cells: maintenance of differentiation and immunomodulatory characteristics. |
| Q39622263 | The HPB-AML-I cell line possesses the properties of mesenchymal stem cells |
| Q88122166 | The Immunomodulatory Properties of Amniotic Cells: The Two Sides of the Coin |
| Q35868449 | The Immunosuppressive Activity of Amniotic Membrane Mesenchymal Stem Cells on T Lymphocytes |
| Q47696722 | The Journey of Islet Cell Transplantation and Future Development. |
| Q35130445 | The MSC: an injury drugstore |
| Q36995514 | The Necessity of a Systematic Approach for the Use of MSCs in the Clinical Setting |
| Q90279588 | The Pros and Cons of Mesenchymal Stem Cell-Based Therapies |
| Q57538743 | The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review |
| Q38228330 | The applications of bone marrow-derived stem cells to induce tolerance and chimerism in organ transplantation |
| Q38210142 | The current landscape of adipose-derived stem cells in clinical applications |
| Q42951008 | The effect of stem cell from human exfoliated deciduous teeth on T lymphocyte proliferation |
| Q36210791 | The fate of systemically administrated allogeneic mesenchymal stem cells in mouse femoral fracture healing |
| Q38106960 | The immune properties of mesenchymal stem cells |
| Q40071382 | The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. |
| Q37866167 | The immunomodulatory properties of mesenchymal stem cells |
| Q33779015 | The introduction of mesenchymal stromal cells induces different immunological responses in the lungs of healthy and M. tuberculosis infected mice |
| Q37790311 | The potential of adipose stem cells in regenerative medicine. |
| Q36054671 | The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis |
| Q39440534 | The potential role of adult stem cells in the management of the rheumatic diseases. |
| Q42069051 | The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population |
| Q36909021 | The study of the feasibility of segmental bone defect repair with tissue- engineered bone membrane: a qualitative observation |
| Q60953449 | Therapeutic Potential of Autologous Adipose-Derived Stem Cells for the Treatment of Liver Disease |
| Q92394670 | Therapeutic Potential of Mesenchymal Stem Cells in Immune-Mediated Diseases |
| Q30319123 | Therapeutic application of mesenchymal stromal cells in autoimmune disease: rationale and initial clinical experience |
| Q35840657 | Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia |
| Q88844378 | Thromboembolism Induced by Umbilical Cord Mesenchymal Stem Cell Infusion: A Report of Two Cases and Literature Review |
| Q35146429 | Tissue engineering for bone production- stem cells, gene therapy and scaffolds |
| Q80568647 | Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon |
| Q42221839 | Toll-like receptors as modulators of mesenchymal stem cells |
| Q64242431 | Tonsil-derived mesenchymal stem cells exert immunosuppressive effects on T cells |
| Q37791614 | Topical delivery of mesenchymal stem cells and their function in wounds |
| Q36444328 | Toward personalized cell therapies by using stem cells: seven relevant topics for safety and success in stem cell therapy. |
| Q33656032 | Transdifferentiation of autologous bone marrow cells on a collagen-poly(ε-caprolactone) scaffold for tissue engineering in complete lack of native urothelium. |
| Q34557484 | Translating research into clinical scale manufacturing of mesenchymal stromal cells |
| Q26860340 | Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement |
| Q53097033 | Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure. |
| Q80413361 | Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells |
| Q33916202 | Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents |
| Q37620545 | Transplantation of umbilical cord mesenchymal stem cells alleviates pneumonitis of MRL/lpr mice |
| Q37995017 | Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives |
| Q36915471 | Transplantation tolerance: lessons from experimental rodent models |
| Q36973330 | Transplanted xenogenic bone marrow stem cells survive and generate new bone formation in the posterolateral lumbar spine of non-immunosuppressed rabbits |
| Q36477364 | Treatment of Hemophilia A in Utero and Postnatally using Sheep as a Model for Cell and Gene Delivery |
| Q38770719 | Treatment of acute graft versus host disease with mesancyhmal stem cells: Questions and answers |
| Q85410833 | Treatment of severe acute graft-versus-host disease with mesenchymal stromal cells: a comparison with non-MSC treated patients |
| Q29618766 | Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells |
| Q80027684 | Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells |
| Q90526363 | Treatment of vocal fold scarring with autologous bone marrow-derived human mesenchymal stromal cells-first phase I/II human clinical study |
| Q40614326 | Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro |
| Q36633057 | Umbilical cord blood-derived mesenchymal stem cells consist of a unique population of progenitors co-expressing mesenchymal stem cell and neuronal markers capable of instantaneous neuronal differentiation. |
| Q38785475 | Unlocking the Potential of Purinergic Signaling in Transplantation |
| Q38072387 | Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review |
| Q80502425 | Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis |
| Q41233584 | Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis |
| Q84600299 | [Mesenchymal cells and fibrocytes in peripheral blood. Culture conditions] |
| Q84742683 | [Mesenchymal stem cells for bone tissue engineering] |
| Q83514683 | [Mesenchymal stromal cells: Biological properties and clinical prospects] |
Search more.